CUE BIOPHARMA, INC.
CUE BIOPHARMA, INC. is a Public Limited Company registered in United States, and its current status with Massachusetts Secretary of the Commonwealth is active. Its registered address on file is Boston, United States. 2 shareholders are on record for CUE BIOPHARMA, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Massachusetts Secretary of the Commonwealth and was last updated on 18 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Shareholders of CUE BIOPHARMA, INC.
Two shareholders are currently on record for CUE BIOPHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is GC Wealth Management RIA, LLC, holding 22.3% — the largest recorded stake — followed by Vanguard Group Inc at 14.5%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| GC Wealth Management RIA, LLC | 22.3% | Massachusetts Secretary of the Commonwealth | |
| Vanguard Group Inc | 14.5% | Massachusetts Secretary of the Commonwealth |
Officers
13
Directors and officers of CUE BIOPHARMA, INC.
The Co-founder And Chairman Of Scientific & Clinical Advisory Board of CUE BIOPHARMA, INC. currently on record is Steven C. Almo Ph.d.; 13 officers are currently on record for CUE BIOPHARMA, INC., filed with Massachusetts Secretary of the Commonwealth. Management authority at CUE BIOPHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of CUE BIOPHARMA, INC.
CUE BIOPHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Cue Biopharma Securities Corp. (United States)
- IMMUNOSCAPE PTE. LTD. (Singapore)
Data availability
Those 2 subsidiaries span United States, Singapore jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
CUE BIOPHARMA, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns CUE BIOPHARMA, INC.?
Two shareholders are currently on record for CUE BIOPHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is GC Wealth Management RIA, LLC, holding 22.3% — the largest recorded stake — followed by Vanguard Group Inc at 14.5%. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is CUE BIOPHARMA, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for CUE BIOPHARMA, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does CUE BIOPHARMA, INC. have on record?
2 shareholders are shown on record for CUE BIOPHARMA, INC..
Is CUE BIOPHARMA, INC. still an active company?
CUE BIOPHARMA, INC.'s status on Massachusetts Secretary of the Commonwealth is listed as active.
What is CUE BIOPHARMA, INC.'s registered address?
The registered address on file for CUE BIOPHARMA, INC. is Boston, United States.
What legal structure is CUE BIOPHARMA, INC. registered as?
CUE BIOPHARMA, INC. is registered as a Public Limited Company in United States.
Who are the officers/directors of CUE BIOPHARMA, INC.?
The Co-founder And Chairman Of Scientific & Clinical Advisory Board of CUE BIOPHARMA, INC. currently on record is Steven C. Almo Ph.d.; 13 officers are currently on record for CUE BIOPHARMA, INC., filed with Massachusetts Secretary of the Commonwealth. Management authority at CUE BIOPHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does CUE BIOPHARMA, INC. have a parent company or subsidiaries?
CUE BIOPHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 2 subsidiaries recorded beneath it across 2 jurisdictions. Those 2 subsidiaries span United States, Singapore jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 2 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to CUE BIOPHARMA, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Massachusetts Secretary of the Commonwealth. Zavia's monitoring API can track changes to CUE BIOPHARMA, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access CUE BIOPHARMA, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like CUE BIOPHARMA, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Massachusetts Secretary of the Commonwealth and was last synced on 18 September 2026.